Skip to content

SANGRIX INC.: 20-F filed 2026-09-18

What SANGRIX INC. reported in its annual report (foreign private issuer) filed 2026-09-18 (fiscal FY 2026): 30 published measures, 75 facts as tagged in accession 0001104659-26-108989.

This filing

Form
20-F (annual report (foreign private issuer))
Filed
2026-09-18
Fiscal period
fiscal FY 2026
Accession
0001104659-26-108989 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All SANGRIX INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2026-06-3021,159,517USD
At 2025-06-303,536,440USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2026-06-3012,081,906USD
At 2025-06-30372,083USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2026-06-305,619,790USD
At 2025-06-303,900,132USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2026-06-301,569,453USD
At 2025-06-3055,639USD

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2025-07-01 to 2026-06-30-2,923,118USD365
2024-07-01 to 2025-06-30-2,290,607USD365
2023-07-01 to 2024-06-30-7,929,234USD366

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2024-07-01 to 2025-06-3039,495USD365
2023-07-01 to 2024-06-302,888,482USD366

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2025-07-01 to 2026-06-304,636,932USD365
2024-07-01 to 2025-06-30-608,712USD365
2023-07-01 to 2024-06-308,298,774USD366

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2025-07-01 to 2026-06-30-200,000USD365
2024-07-01 to 2025-06-301,545,888USD365
2023-07-01 to 2024-06-301,023,256USD366

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2025-07-01 to 2026-06-30339,699shares365
2024-07-01 to 2025-06-3077,016shares365
2023-07-01 to 2024-06-3017,472shares366

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2025-07-01 to 2026-06-30339,699shares365
2024-07-01 to 2025-06-3077,016shares365
2023-07-01 to 2024-06-3017,472shares366

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2025-07-01 to 2026-06-30-70.43USD/shares365
2024-07-01 to 2025-06-30-84.84USD/shares365
2023-07-01 to 2024-06-30-1,003.41USD/shares366

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2025-07-01 to 2026-06-30-70.43USD/shares365
2024-07-01 to 2025-06-30-84.84USD/shares365
2023-07-01 to 2024-06-30-1,003.41USD/shares366

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2023-07-01 to 2024-06-3073,230USD366

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2025-07-01 to 2026-06-30-14,279,433USD365
2024-07-01 to 2025-06-30-2,991,693USD365
2023-07-01 to 2024-06-30-14,835,793USD366

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2026-06-3010,168,048USD
At 2025-06-303,536,440USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2026-06-301,457,088USD
At 2025-06-30372,083USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2025-07-01 to 2026-06-3014,279,433USD365
2024-07-01 to 2025-06-303,031,188USD365
2023-07-01 to 2024-06-3013,890,591USD366

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2024-07-01 to 2025-06-3039,495USD365
2023-07-01 to 2024-06-30-945,202USD366

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2026-06-30117,330,148USD
At 2025-06-3092,165,483USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2026-06-30480,001USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2026-06-304,876,304USD
At 2025-06-303,164,357USD
At 2024-06-30909,583USD
At 2023-06-3010,261,071USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2025-07-01 to 2026-06-30-14,293,365USD365
2024-07-01 to 2025-06-30-4,369,906USD365
2023-07-01 to 2024-06-30-18,284,958USD366

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2025-07-01 to 2026-06-30-14,293,365USD365
2024-07-01 to 2025-06-30-4,369,906USD365
2023-07-01 to 2024-06-30-18,284,958USD366

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2025-07-01 to 2026-06-30-13,805,653USD365
2024-07-01 to 2025-06-30-4,387,192USD365
2023-07-01 to 2024-06-30-17,531,647USD366

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2025-07-01 to 2026-06-30-23,925,173USD365
2024-07-01 to 2025-06-30-6,533,987USD365
2023-07-01 to 2024-06-30-17,531,647USD366

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2025-07-01 to 2026-06-302,754,038USD365
2024-07-01 to 2025-06-303,082,820USD365
2023-07-01 to 2024-06-303,816,307USD366

Nonoperating interest expense

Interest expense presented outside operating results. It differs from total interest expense when some borrowing cost is classified as operating or capitalized.

PeriodValueUnitDays
2024-07-01 to 2025-06-30665,194USD365
2023-07-01 to 2024-06-30595,685USD366

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2025-07-01 to 2026-06-30-13,932USD365
2024-07-01 to 2025-06-30-1,378,213USD365
2023-07-01 to 2024-06-30-3,449,165USD366

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2025-07-01 to 2026-06-30613,505USD365
2024-07-01 to 2025-06-30608,712USD365
2023-07-01 to 2024-06-30270,170USD366

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2023-07-01 to 2024-06-30-667,912USD366

Inspect the source

Entity
SANGRIX INC. / CIK 0001735556
Captured
2026-09-21T17:25:29.977Z
SEC response SHA-256
35347f73859e801269c4493170eef9dfdd81524d77cc5cae387663aaf840b97a

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001735556.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))